Comparison of breath-enhanced to breath-actuated nebulizers for rate, consistency, and efficiency

被引:45
作者
Leung, K [1 ]
Louca, D [1 ]
Coates, AL [1 ]
机构
[1] Hosp Sick Children, Div Resp Med & Lung Biol Res, Inst Res, Toronto, ON M5G 1X8, Canada
关键词
aerosols; asthma; breath-actuated nebulizers; breath-enhanced nebulizers; cystic fibrosis; pediatrics;
D O I
10.1378/chest.126.5.1619
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: To evaluate differences between three new-generation nebulizers-Pari LC Star (Pari Respiratory Equipment; Mississauga, ON, Canada), AeroEclipse (Trudell Medical International, London, ON, Canada), and Halolite (Medic-Aid Limited, West Sussex, UK)-in terms of rate and amount of expected deposition as well as the consistency of the doses delivered. Methods: The in vitro performance characteristics were determined and then coupled to the respiratory pattern of seven patients with cystic fibrosis (age range, 4 to 18 years) in order to calculate expected deposition. The Pari LC Star and AeroEclipse were characterized while being driven by the Pari ProNeb Ultra compressor (Pari Respiratory Equipment) for home use, and by a 50-psi medical air hospital source. The Halolite has its own self-contained compressor. Algorithms for the rate of output for the inspiratory flow were developed for each device. Patient floNv patterns were divided into 5-ms epochs, and the expected deposition for each epoch was calculated from the algorithms. Summed over a breath, this allowed the calculation of the estimated deposition for each patient's particular pattern of breathing. Results: The rate of deposition was highest for the Pari LC Star and lowest for the Halolite. Rate of deposition was independent of respiratory pattern for the Pari LC Star and AeroEclipse, but proportional to respiratory rate for the Halolite. The differences between the Pali LC Star and AeroEclipse were less when driven by the 50-psi source. The AeroEclipse had the least amount of drug wastage. As designed, the Halolite delivered a predetermined amount of drug very accurately, whereas expected deposition when run to dryness of the other two devices had significant variations. Conclusions: To minimize treatment time, the Pari LC Star would be best. To minimize drug wastage, the AeroEclipse would be best. To accurately deliver a specific drug dose, the Halolite would be best.
引用
收藏
页码:1619 / 1627
页数:9
相关论文
共 25 条
[1]   Health perceptions and treatment adherence in adults with cystic fibrosis [J].
Abbott, J ;
Dodd, M ;
Webb, AK .
THORAX, 1996, 51 (12) :1233-1238
[2]  
Abbott J, 2001, DISABIL REHABIL, V23, P315
[3]   Contemporary psychosocial issues in cystic fibrosis: treatment adherence and quality of life [J].
Abbott, J ;
Gee, L .
DISABILITY AND REHABILITATION, 1998, 20 (6-7) :262-271
[4]   THE USE OF LASER DIFFRACTION FOR THE EVALUATION OF THE AEROSOL CLOUDS GENERATED BY MEDICAL NEBULIZERS [J].
CLARK, AR .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 115 (01) :69-78
[5]   FACTORS INFLUENCING THE SIZE DISTRIBUTION OF AEROSOLS FROM JET NEBULIZERS [J].
CLAY, MM ;
PAVIA, D ;
NEWMAN, SP ;
CLARKE, SW .
THORAX, 1983, 38 (10) :755-759
[6]   The choice of jet nebulizer, nebulizing flow, and addition of albuterol affects the output of tobramycin aerosols [J].
Coates, AL ;
MacNeish, CF ;
Meisner, D ;
Kelemen, S ;
Thibert, R ;
MacDonald, J ;
Vadas, E .
CHEST, 1997, 111 (05) :1206-1212
[7]   Accounting for radioactivity before and after nebulization of tobramycin to insure accuracy of quantification of lung deposition [J].
Coates, AL ;
Dinh, L ;
MacNeish, CF ;
Rollin, T ;
Gagnon, S ;
Ho, SL ;
Lands, LC .
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 2000, 13 (03) :169-178
[8]   A comparison of the availability of tobramycin for inhalation from vented vs unvented nebulizers [J].
Coates, AL ;
MacNeish, CF ;
Lands, LC ;
Meisner, D ;
Kelemen, S ;
Vadas, EB .
CHEST, 1998, 113 (04) :951-956
[9]  
Coates AL, 1998, PEDIATR PULM, V26, P412, DOI 10.1002/(SICI)1099-0496(199812)26:6<412::AID-PPUL6>3.3.CO
[10]  
2-F